Skip to content
Screener

Celcuity CELC Income Tax

Income Tax at other companies

Eli Lilly logo
Eli LillyLLY
$2.15B+92.8%
Gilead Sciences logo
Gilead SciencesGILD
$242M-48.3%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$60K-4.8%
CTO
Citius Oncology, Inc.CTOR
-$231.21K-188%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Celcuity’s 10-Q, filed August 11, 2021. Open the filing →

Filed
Aug 11, 2021, 5:04 PM EDT
Fiscal quarter
Q2 FY2021
Calendar quarter
Q2 2021
Accession
0001654954-21-008769

FAQ

What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.